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A report on the Biochemical Society meeting ‘Systems biology:
will it work?’, Sheffield, UK, 5 January 2005.
The idea of systems biology is not new: as long ago as 1968,
the mathematician and engineer Mihajlo Mesarovic regretted
that “in spite of considerable interest and efforts, the applica-
tion of systems theory in biology has not quite lived up to
expectation”. But what of systems biology today? Does it now
look more likely to lead to the expected benefits? These ques-
tions are of particular urgency in the UK at a time when the
Biotechnology and Biological Sciences Research Council
(BBSRC) is planning to create six new centers for systems
biology over the next two years, investing £6 million in each.
It was in the hope of answering them that a one-day meeting
exploring the nature of systems biology and its potential was
organized by the Biochemical Society early this year.
In the 1950s the geneticist and biochemist Henrik Kacser
was already urging biologists to take systems seriously: “The
problem is … the investigation of systems, i.e. components
related or organised in a specific way. The properties of a
system are in fact ‘more’ than (or different from) the sum of
the properties of its components, a fact often overlooked in
zealous attempts to demonstrate ‘additivity’ of certain phe-
nomonena. It is with these ‘systemic properties’ that we shall
be mainly concerned...”. 
To most people, however, ‘systems biology’ is still just a
combination of words they encounter with increasing fre-
quency in the literature - a search of PubMed on 3 January
2005 produced 11 hits for the new year, more than for all the
years before 1998, suggesting that the total of 316 mentions
in 2004 will easily be exceeded this year. The range of opin-
ions expressed at the Sheffield meeting was enlightening,
but might leave the outsider none the wiser. It would be an
exaggeration to say that each speaker offered a distinct and
incompatible opinion about what systems biology is, but
there was certainly less unanimity about the nature of the
subject matter than there is at most research meetings. One
speaker even announced that “before I came to this meeting
I didn’t know what systems biology was”, and answers to the
question posed by the meeting’s title ranged from scepticism
to the unambiguous “Yes!” with which Hans Westerhoff
(Free University of Amsterdam, The Netherlands) entitled
his contribution.
To sceptics such as myself, systems biology sometimes
appears to be little more than a new name for old-fashioned
reductionist biology practised on an ever-larger scale, with
ever-larger and more expensive machines. That is certainly
not what Kacser meant. Nor did the theoretical biologist
Ludwig von Bertalanffy, the founder of systems theory, who
described what he saw as the analytical obsession of modern
science, the splitting up of reality into smaller and smaller
units, as a “malady”. 
In attempting to define systems biology, Olaf Wolkenhauer
(University of Rostock, Germany) emphasized the need for a
shift in focus away from molecular characterization towards
understanding functional activity. He argued that systems
biology must be different from genomics and bioinformatics,
and the same point was later made by Alf Game (BBSRC,
Swindon, UK), who gave “genomics plus computers” as an
example of what systems biology is not. I argued for renewed
attention to Erwin Schrödinger’s famous question “What is
Life?” and for serious attempts to build on the theoretician
Robert Rosen’s life’s work in trying to answer it. Failure to
do this will mean that genetic engineering will never become
more than glorified tinkering. 
Last year’s Nobel prizewinner for physics, theoretical physi-
cist Frank Wilczek, said in a recent interview that he still
mainly uses pencil and paper in his work. Similarly, investi-
gating complex biological systems does not necessarily need
large financial investment but rather a significant invest-
ment in intellectual resources. Nevertheless, a genuinelysystemic view is not incompatible with gathering huge quan-
tities of experimental data. This was well illustrated by
Douglas Kell (University of Manchester, UK), who empha-
sized that studying bits of a system will not lead to under-
standing the whole. He argued that it is not a question of
replacing a tried and true approach with an untried one, but
of replacing an approach that is reaching the limits of its
possibilities with one that will, if applied properly, allow
continued advances towards understanding systems. Kell
discussed his group’s analysis of the transcription factor
NF-κB that indicates the necessity of taking account not only
of the amplitude of its oscillations of activity but also of the
frequency of these oscillations. This may seem unduly com-
plicated to those who hoped to see a simpler message in such
signals, but frequency may well fulfill a necessary physiologi-
cal function, as using it as well as amplitude allows a system
to avoid undesirable cross-talk between signals that rely on
the same chemical entities.
In some cases, the systems approach is already working at a
sophisticated level. As Denis Noble (University of Oxford,
UK) pointed out, models of heart function have now reached
astonishing levels of detail, accuracy and predictive power.
He illustrated this with realistic simulations of normal and
abnormal hearts beating, based on real measurements,
which were developed in collaboration with Peter Hunter
(University of Auckland, New Zealand). Noble had predicted
that about 1027 computers of the power of the IBM super-
computer Blue Gene would be needed to compute the behav-
ior of a single cell in full. In practice, ordinary computers can
tackle the task vastly better than this pessimistic calculation
implies. As he pointed out, the better performance is due to a
fair degree of modularity in nature: many separate functions
are handled independently, and are only integrated into a
single model at the end. Moreover, with sufficient under-
standing of the system under study one can select the data
that need to be included in the model: despite the good
results given by his heart model, Noble estimates that it
includes only about 2% of the proteins that are believed to be
expressed in the heart.
A systems approach to cell biology naturally needs to know
where the system components are located in the cell. Bob
Murphy (Carnegie-Mellon University, Pittsburgh, USA) dis-
cussed the degree of expertise needed to identify proteins by
fluorescence microscopy. Machine-learning techniques can
train a program to recognize the subcellular locations of pro-
teins from the morphological features visible in fluorescence
images, and now allow computers to do tasks that humans
find difficult or impossible. For example, a trained program
can distinguish between different Golgi proteins in such
images with fair accuracy, even though expert humans can
barely see any difference.
Putting the case for systems biology, Westerhoff described
examples of how a systemic view has allowed not only a
better understanding of how organisms behave, but also
much better prediction of how they will respond to manipu-
lation. For example, finding drugs to combat African try-
panosomiasis means choosing the right potential drug target
in the trypanosome parasite. This requires sufficient knowl-
edge of the metabolism of the parasite and its host to predict
what is likely to happen if a given enzyme in the parasite is
inhibited. We will know how well this works in practice for
treating the disease when studies become available that are
currently carried out at the University of Washington in col-
laboration with Westerhoff’s group. 
In a striking image, Rob Beynon (University of Liverpool,
UK) pointed out that a mouse has a new liver every day - vir-
tually all its liver cells are replaced. For him, neither the
transcriptome nor the metabolome are fixed entities; they
need to be treated in terms of a dynamic exchange, with
amino acids constantly being converted into proteins, and
proteins being degraded into amino acids. His experiments
with labeling leucine residues in proteins with deuterium
and measuring how fast the labels disappear have allowed
measurement of how fast particular proteins are degraded,
and this shows that protein turnover is highly variable. Some
proteins disappear in a matter of minutes, whereas others
are effectively immortal, with no detectable loss during the
duration of an experiment. The balance between synthesis
and degradation is maintained by kinetic considerations,
and this means that an organism must be treated as a
dynamic system that is changing all the time. 
The many aspects to consider when setting up even a highly
simplified model imply, therefore, that making systems
biology work will never be easy. However, difficult or not,
there is no alternative. As Kell remarked, as his answer to
the question in the meeting’s title, “the not-system approach
does not work”.
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